Page last updated: 2024-11-05

butyl methacrylate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Butyl methacrylate (BMA) is a colorless liquid monomer with a mild odor. It is produced by the esterification of methacrylic acid with butanol. BMA is a versatile monomer used in the production of various polymers, including acrylic resins, adhesives, paints, and coatings. Its importance lies in its ability to provide desirable properties to these materials, such as flexibility, toughness, and weather resistance. BMA is studied for its potential applications in various fields, including biomedical engineering, electronics, and construction. Its biocompatibility and non-toxicity make it a promising material for biomedical applications. BMA is also used in the synthesis of copolymers with other monomers, leading to polymers with tailored properties. Research on BMA focuses on understanding its polymerization mechanism, developing new and efficient polymerization techniques, and exploring its potential applications in various industries.'

Cross-References

ID SourceID
PubMed CID7354
CHEMBL ID3183073
CHEBI ID180322
SCHEMBL ID14893
MeSH IDM0066198

Synonyms (79)

Synonym
CHEBI:180322
butyl 2-methylprop-2-enoate
2-propenoic acid, 2-methyl-, butyl ester
97-88-1
methacrylate de butyle
butyl 2-methacrylate
butyl 2-methyl-2-propenoate
nsc-20956
2-methyl-butylacrylat
2-methyl-butylacrylate
wln: 4ovy1 & u1
butylmethacrylaat
methacrylsaeurebutylester
methacrylic acid, butyl ester
butil metacrilato
nsc20956
butyl methacrylate
n-butyl methacrylate
2-methylacrylic acid, butyl ester
2-methyl-butylacrylaat
butyl 2-methylacrylate
inchi=1/c8h14o2/c1-4-5-6-10-8(9)7(2)3/h2,4-6h2,1,3h
butil metacrilato [italian]
einecs 202-615-1
ai3-25420
ccris 4760
2-methyl-butylacrylaat [dutch]
nsc 20956
butylester kyseliny methakrylove [czech]
butyl methacrylate monomer
un2227
hsdb 289
methacrylate de butyle [french]
brn 0773960
butylmethacrylate
butylmethacrylaat [dutch]
methacrylsaeurebutylester [german]
2-methyl-butylacrylat [german]
butyl methacrylate, 99%, contains 10 ppm monomethyl ether hydroquinone as inhibitor
methacrylic acid butyl ester
M0081
pbma
NCGC00248544-01
AKOS005720977
tox21_200161
dtxcid704696
dtxsid4024696 ,
NCGC00257715-01
cas-97-88-1
BBL011464
FT-0689210
STL146576
butylester kyseliny methakrylove
n-butyl methacrylate, inhibited [un2227] [flammable liquid]
ec 202-615-1
r5qx287xxu ,
unii-r5qx287xxu
n-butyl methacrylate, inhibited
SCHEMBL14893
n-butyl methacrylate [hsdb]
butyl methacrylate [inci]
n-butylmethacrylate
nbma
butyl ester of methacrylic acid
methacrylic acid n-butyl ester
un 2227 (salt/mix)
2-methyl-2-propenoic acid butyl ester
butyl 2-methyl-2-propenate
butyl 2-methylacrylate #
CHEMBL3183073
J-519966
mfcd00009444
butyl methacrylate, (stabilized with hq)
butyl methacrylate (stabilized with hq)
butyl methacrylate, european pharmacopoeia (ep) reference standard
methacrylic acid-butyl ester
VS-02953
Q10329087
AMY4150

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" This study aimed to examine possible time-dependent toxic effects of provisional crown and bridge restoration materials, manipulated intraorally or extraorally, on epithelia cells."( Cytotoxicity of provisional crown and bridge restoration materials: an in vitro study.
Dogan, A; Ergün, G; Karaoglu, T; Mutlu-Sagesen, L, 2001
)
0.31

Bioavailability

ExcerptReferenceRelevance
" Results indicated that, although larger molecular weight PEG decreased cellular internalization, it improved cytoplasmic bioavailability due to increased intracellular unpackaging (quantitatively measured via FRET) and endosomal release."( Tuning PEGylation of mixed micelles to overcome intracellular and systemic siRNA delivery barriers.
Duvall, CL; Giorgio, TD; Gupta, MK; Kilchrist, KV; Kirkbride, KC; Li, H; Miteva, M; Nelson, CE; Werfel, TA, 2015
)
0.42
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
enoate esterAn alpha,beta-unsaturated carboxylic ester of general formula R(1)R(2)C=CR(3)-C(=O)OR(4) (R(4) =/= H) in which the ester C=O function is conjugated to a C=C double bond at the alpha,beta position.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (6)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
RAR-related orphan receptor gammaMus musculus (house mouse)Potency49.49750.006038.004119,952.5996AID1159521; AID1159523
AR proteinHomo sapiens (human)Potency9.87600.000221.22318,912.5098AID743040
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency56.02500.000214.376460.0339AID720691
estrogen nuclear receptor alphaHomo sapiens (human)Potency20.33690.000229.305416,493.5996AID1259244; AID743075; AID743079
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency19.70530.001557.789015,848.9004AID1259244
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency19.70530.001551.739315,848.9004AID1259244
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Research

Studies (157)

TimeframeStudies, This Drug (%)All Drugs %
pre-199010 (6.37)18.7374
1990's25 (15.92)18.2507
2000's39 (24.84)29.6817
2010's72 (45.86)24.3611
2020's11 (7.01)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 47.38

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index47.38 (24.57)
Research Supply Index5.12 (2.92)
Research Growth Index4.95 (4.65)
Search Engine Demand Index74.75 (26.88)
Search Engine Supply Index2.05 (0.95)

This Compound (47.38)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (1.22%)5.53%
Reviews1 (0.61%)6.00%
Case Studies2 (1.22%)4.05%
Observational0 (0.00%)0.25%
Other159 (96.95%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]